Peptides DB
Research-centric peptide and protocol reference hub

Cibinetide record · updated 7h ago

Neuro & moodHealing & recoveryGrade A · human clinicalResearch use only
All 4 studiesJump to the evidenceCompare
What is Cibinetide used for?

Research peptide discovered via AI researcher. peptide-based therapeutic

How it works: Cytoprotection and modulation of inflammatory responses

Primarily researched for · Neuro & mood

Development stage

where Cibinetide sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 1 registered trial. It describes the research record, not a recommendation.

Identity
NameCibinetide
Chain length—
Molecular weight1,257.3 Da
FormulaC51H84N16O21
Structure typeNot established
ClassNeuro
Research levelPreclinical
Discovered byThe Librarian · 2026

Mass and formula from PubChem CID 91810664. No verified residue count for this compound.

Pharmacology
MechanismCytoprotection and modulation of inflammatory responses
Route—
Half-life—
Time to peak—
Duration—
Extraction confidence0.50
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Aug 29, 2026. How this works →
Research stats
Total studies4
Human / animal / cellular0 / 2 / 0
Highest trial phasePreclinical
Years covered2025
Latest study1d ago
Publication history
20252025
Research funding
—no NIH grants found
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

4 rowsOpen in the library →
StudyTypeYearSummary depth
Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope-Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice.
Finding30% to 80% decrease in clinical score, P < 0.05.
Animal2025Full text read0.80
Initial estimates of the minimal clinically important difference for the Neuropathic Pain Symptom Inventory: a systematic meta-analysis.
FindingMCID for NPSI total score was 6.21 for SD of change meta-regression.
review2025Full text read0.80
Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy.
FindingNot reported in abstract.
review2025Full text read0.70
ARA290 Attenuates Apical Periodontitis via SIRT1/NF-κB/IL-1β Pathway Modulation.
Finding50% reduction in SIRT1 expression within periapical lesions in AP model.
Animal2025Full text read0.80

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Cibinetide will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much Cibinetide is discussed should be drawn from it.